Regulation of PDGF-stimulated SHIP2 tyrosine phosphorylation and association with Shc in 3T3-L1 preadipocytes

Journal of Cellular Physiology

Volumn 211, Issue 3, 2007, Pages 598-607

  Artemenko, Y ^a   Gagnon, A ^a   Ibrahim, S ^a   Sorisky, A ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; BISINDOLYLMALEIMIDE; INOSITOL 1 PHOSPHATASE; MUTANT PROTEIN; PHENYLALANINE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3,4 BISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE C; PROTEIN SH2; PROTEIN SHC; PROTEIN SHIP2; THREONINE; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADIPOCYTES; AMINO ACID SUBSTITUTION; ANIMALS; CELL DIVISION; DRUG INTERACTIONS; ENZYME INHIBITORS; HUMANS; INDOLES; MALEIMIDES; MICE; MUTAGENESIS, SITE-DIRECTED; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROTEIN KINASE C; TRANSFECTION; TYROSINE;

EID: 34247574611     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20965     Document Type: Article

References (39)

1. Artemenko Y, Gagnon A, Aubin D, Sorisky A. 2005. Anti-adipogenic effect of PDGF is reversed by PKC inhibition. J Cell Physiol 204:646-653.
2. Astle MV, Seaton G, Davies EM, Fedele CG, Rahman P, Arsala L, Mitchell CA. 2006. Regulation of phosphoinositide signaling by the inositol polyphosphate 5-phosphatases. IUBMB Life 58:451-456.
3. Backers K, Blero D, Paternotte N, Zhang J, Erneux C. 2003. The termination of PI3K signalling by SHIP1 and SHIP2 inositoi 5-phosphatases. Advan Enzyme Regul 43:15-28.
4. Bell A, Gagnon A, Dods P, Papineau D, Tiberi M, Sorisky A. 2002. TSH signaling and cell survival in 3T3-L1 preadipocytes. Am J Physiol: Cell Physiol 283:C1056-C1064.
5. Benkirane K, Amiri F, Diep QN, El Mabrouk M, Schiffrin EL. 2006. PPARγ inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1. Am J Physiol: Heart Circ Physiol 290:H390-H397.
6. Blero D, De Smedt F, Pesesse X, Paternotte N, Moreau C, Payrastre B, Erneux C. 2001. The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin. Biochem Biophys Res Commun 282:839-843.
7. Blero D, Zhang J, Pesesse X, Payrastre B, Dumont JE, Schurmans S, Erneux C. 2005. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts. FEBS J 272:2512-2522.
8. Choi Y, Zhang J, Murga C, Yu H, Koller E, Monia BP, Gutkind JS, Li W. 2002. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Oncogene 21:5289-5300.
9. Dyson JM, O'Malley CJ, Becanovic J, Munday AD, Berndt MC, Coghill ID, Nandurkar HH, Ooms LM, Mitchell CA. 2001. The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin. J Cell Biol 155:1065-1079.
10. Gagnon A, Chen C-S, Sorisky A. 1999. Activation of protein kinase B and induction of adipogenesis by insulin in 3T3-L1 preadipocytes. Contribution of phosphoinositide-3,4,5-trisphosphate versus phosphoinositide-3,4-bisphosphate. Diabetes 48:691-698.
11. Gagnon A, Artemenko Y, Crapper T, Sorisky A. 2003. Regulation of endogenous SH2 domain-containing inositol 5-phosphatase (SHIP2) in 3T3-L1 and human preadipocytes. J Cell Physiol 197:243-250.
12. Gagnon A, Landry A, Proulx J, Layne MD, Sorisky A. 2005. Aortic carboxypeptidase-like protein is regulated by transforming growth factor β in 3T3-L1 preadipocytes. Exp Cell Res 308:265-272.
13. Giuriato S, Blero D, Robaye B, Bruyns C, Payrastre B, Erneux C. 2002. SHIP2 overexpression strongly reduces the proliferation rate of K562 erythroleukemia cell line. Biochem Biophys Res Commun 296:106-110.
14. Gual P, Le Marchand-Brustel Y, Tanti JF. 2005. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87:99-109.
15. Habib T, Hejna JA, Moses RE, Decker SJ. 1998. Growth factors and insulin stimulate tyrosine phosphorylation of the 51C/SHIP2 protein. J Biol Chem 273:18605-18609.
16. Hauner H, Rohrig K, Petruschke T. 1995. Effects of epidermal growth factor (EGF), platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) on human adipocyte development and function. Eur J Clin Invest 25:90-96.
17. Ishihara H, Sasaoka T, Hori H, Wada T, Hirai H, Haruta T, Langlois WJ, Kobayashi M. 1999. Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling. Biochem Biophys Res Commun 260:265-272.
18. Ishihara H, Sasaoka T, Ishiki M, Wada T, Hori H, Kagawa S, Kobayashi M. 2002. Membrane localization of Src homology 2-containing inositol 5-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors. Mol Endocrinol 16:2371-2381.
19. Kagawa S, Sasaoka T, Yaguchi S, Ishihara H, Tsuneki H, Murakami S, Fukui K, Wada T, Kobayashi S, Kimura I, Kobayashi M. 2005. Impact of SRC homology 2-containing inositol 5′-phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling. J Clin Endocrinol Metab 90:2911-2919.
20. Krieger-Brauer HI, Kather H. 1995. Antagonistic effects of different members of the fibroblast and platelet-derived growth factor families on adipose conversion and NADPH-dependent H2O2 generation in 3T3-L1 cells. Biochem J 307:549-556.
21. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
22. Lazar DF, Saltiel AR. 2006. Lipid phosphatases as drug discovery targets for type 2 diabetes. Nat Rev Drug Discov 5:333-342.
23. Liu XJ, Sorisky A, Zhu L, Pawson T. 1995. Molecular cloning of an amphibian insulin receptor substrate 1-like cDNA and involvement of phosphatidylinositol 3-kinase in insulin-induced Xenopus oocyte maturation. Mol Cell Biol 15:3563-3570.
24. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C. 1993. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268:9194-9197.
25. Paternotte N, Zhang J, Vandenbroere I, Backers K, Blero D, Kioka N, Vanderwinden JM, Pirson I, Erneux C. 2005. SHIP2 interaction with the cytoskeletal protein vinexin. FEBS J 272:6052-6066.
26. Pear WS, Nolan GP, Scott ML, Baltimore D. 1993. Production of high-titre helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90:8392-8396.
27. Pengal RA, Ganesan LP, Fang H, Marsh CB, Anderson CL, Tridandapani S. 2003. SHIP-2 inositol phosphatase is inducibly expressed in human monocytes and serves to regulate Fcgamma receptor-mediated signaling. J Biol Chem 278:22657-22663.
28. Pesesse X, Dewaste V, De Smedt F, Laffargue M, Giuriato S, Moreau C, Payrastre B, Erneux C. 2001. The Src homology 2 domain containing inositol 5-phosphatase SH1P2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells. J Biol Chem 276:28348-28355.
29. Prasad N, Topping RS, Decker SJ. 2001. SH2-containing inositol 5-phosphatase SHIP2 associates with the p130Cas adapter protein and regulates cellular adhesion and spreading. Mol Cell Biol 21:1416-1428.
30. Prasad N, Topping RS, Decker SJ. 2002. Src family tyrosine kinases regulate adhesion-dependent tyrosine phosphorylation of 5-inositol phosphatase SHIP2 during cell attachment and spreading on collagen I. J Cell Sci 115:3807-3815.
31. Roskoski RJ. 2005. Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 331:1-14.
32. Salomon AR, Ficarro SB, Brill LM, Brinker A, Phung QT, Ericson C, Sauer K, Brock A, Horn DM, Schultz PG, Peters EC. 2003. Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. Proc Natl Acad Sci USA 100:443-448.
33. Sasaoka T, Hori H, Wada T, Ishiki M, Haruta T, Ishihara H, Kobayashi M. 2001. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes. Diabetologia 44:1258-1267.
34. Sorisky A, Pardasani D, Lin Y. 1996. The 3-phosphorylated phosphoinositide response of 3T3-L1 preadipose cells exposed to insulin, insulin-like growth factor-1, or platelet-derived growth factor. Obes Res 4:9-19.
35. Tang X. Powelka AM, Soriano NA, Czech MP, Guilherme A. 2005. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatrdylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes. J Biol Chem 280:22523-22539.
36. Taylor V, Wong M, Brandts C, Reilly L, Dean NM, Cowsert LM, Moodie S, Stokoe D. 2000. 5′ Phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells. Mol Cell Biol 20:6860-6871.
37. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J. 1991. The bisindoylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266:15771-15781.
38. Wada T, Sasaoka T, Funaki M, Hori H, Murakami S, Ishiki M, Haruta T, Asano T, Ogawa W, Ishihara H, Kobayashi M. 2001. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5′-phosphatase catalytic activity. Mol Cell Biol 21:1633-1646.
39. Wisniewski D, Strife A, Swendeman S, Erdjument-Bromage H, Geromanos S, Kavanaugh WM, Tempst P, Clarkson B. 1999. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells. Blood 93:2707-2720.